The global molecular
diagnostics market is foreseen to grow by 4.7%, from USD 21.63 Billion in 2021
to USD 31.23 Billion in 2029. Increasing prevalence of infectious diseases and
cancer, rising focus on R&D and growing funding in molecular diagnostics, growing
awareness of early disease diagnosis in developing countries, rising
technological advancements in molecular diagnostics is to drive the market for
the upcoming forecast period. However, unfavorable reimbursement scenario, high
cost of instruments remains one factor hindering the market growth over the
What Is Molecular Diagnostics?
The goal of molecular diagnostics, also known as the
identification of genetic variations, is to make it easier to detect, diagnose,
classify, predict outcomes, and track therapeutic responses.
molecular diagnostics market search study helps to thoroughly understand
the current trend in the market competitive analysis of the players in the
emerging market. Moreover, the DRO in the molecular diagnostics market offers
valuable perspicuity and a current scenario for making the right decision. The
research study covers the eminent players in the market with a detailed
analysis of the company and a financial overview containing their net sales,
business mix and geographical reach It mainly focuses on the key developments
of the products/services offered by the company in recent years. Besides, we at
Zettabyte have the expertise to analyses the global Molecular diagnostics
market player's competitive landscape helping the client comprehend their
specific strategic growth approaches.
diagnostics market study by "Zettabyte Analytics" offers details
about the market scope, market segmentation, technological advancement in the Molecular
diagnostics market and highlights the optimistic, competitive landscape and
trends enduring over the years.
Major players in
the Molecular diagnostics market include Abacus Diagnostica Oy, Abbott
Laboratories, Agilent Technologies, Inc., Amoy Diagnostics Co., Ltd., Becton,
Dickinson And Company, Biocartis Nv, Biomérieux Sa, Danaher Corporation,
Diasorin S.P.A., Elitechgroup, Exact Sciences Corporation, F. Hoffmann-La Roche
Ltd, Geneombio Technologies Pvt. Ltd., Genetic Signatures, Grifols, S.A.,
Hologic, Inc., Htg Molecular Diagnostics, Inc., Illumina, Inc., Mdxhealth,
Molbio Diagnostics Pvt. Ltd., Myriad Genetics, Inc., Perkinelmer, Inc., Qiagen
N.V., Quidel Corporation, Savyon Diagnostics, Siemens Healthineers Ag, Tbg
Diagnostics Limited, Thermo Fisher Scientific, Inc., Vela Diagnostics.
COVID-19 Impact on Global Molecular
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the Molecular diagnostics
market has forced the companies to change their sourcing, pricing, and
promotion strategies. the molecular diagnostics market players are seen focusing
more on optimizing the e-commerce networks with the rising innovations in the
digital sector, which are creating new business models for the healthcare industry
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
dynamics, regulatory scenarios, major material dynamics and Molecular
diagnostics market future markets are analyzed to understand their impact on demand
for the forecast period. growth rates have been estimated using correlation,
regression and time-series analysis.
For the purpose
of this report, the global molecular diagnostics market segmented on the basis
of product & service, test type, technology, application, end user, and
Product & Service Outlook:
On the basis of
product & service, the market is segmented into reagents & kits,
instruments, services & software.
Test Type Outlook:
On the basis of
Test Type, the market is segmented into Lab Tests, PoC Tests.
On the basis of
Technology, the market is segmented into Polymerase Chain Reaction (PCR),
Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing &
Next- generation Sequencing (NGS), In Situ Hybridization (ISH), DNA
Microarrays, Other Technologies.
Figure 1 Molecular diagnostics market By Technology
(Market Size And Forecast By Value - USD Million, 2021 & 2029)